Trump Announces 100% Tariff on Imported Generic Drugs

U.S. President Donald Trump announced on Tuesday that the administration will impose a 100 % tariff on imported generic pharmaceutical drugs. The measure is intended to stimulate domestic production of medicines and reduce reliance on foreign suppliers. The tariff is scheduled to take effect in August 2028, giving industry stakeholders several years to adjust to the new pricing structure.

The policy follows a broader trend of protectionist actions aimed at securing supply chains for critical goods. By doubling the cost of imported generics, the administration hopes to create a more favorable environment for U.S. manufacturers to expand capacity and invest in research and development. Critics argue that the tariff could raise drug prices for consumers, while supporters contend it will enhance national security and foster innovation.

The announcement marks a significant shift in U.S. trade policy toward pharmaceuticals. Stakeholders in the healthcare sector, including manufacturers, insurers, and patient advocacy groups, will closely monitor the implementation timeline and potential regulatory adjustments required to comply with the new tariff regime.